Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes

Table 5

Clinical profiles, admission therapy, and outcomes in men and women.

	ACS alone			Polyvascular disease
	Men	Women	P value	Men	Women	P value
Age (yrs, mean)	55±12	61±12	0.001	64±12	65±13	0.19
Diabetes mellitus %	35	51	0.001	63	74	0.03
Hypertension %	40.5	64	0.001	76	81	0.24
Dyslipidemia %	34	44	0.001	53	63	0.55
Smoking %	65	10	0.001	57	16	0.001
Renal failure %	3	5	0.001	16	13	0.44
Admission therapy (%)
Aspirin	98.6	98.5	0.75	96	97	0.51
Clopidogrel	79	64	0.001	82	79	0.51
Beta blockers	76	71	0.001	70	63	0.11
ACE inhibitors	71	72	0.72	70	65	0.31
Heparin	58	59	0.98	41	37	0.50
Glycoprotein inhibitors	8.3	5.2	0.001	9	6	0.23
Statin	95	94	0.01	92	94	0.57
PCI	23	19	0.01	13	10.5	0.55
Outcomes (%)
Reischemia	14	18	0.001	21	27	0.17
Heart failure	10.7	15.5	0.001	29	34	0.28
Hospital mortality	3.7	6.3	0.001	8.6	10.8	0.46
1-month mortality	6.8	9.7	0.001	15	20	0.26
12-month mortality	10.3	15	0.001	23	29	0.22